Trulieve Cannabis Corp. (TCNNF) Stock

HealthcareDrug Manufacturers - Specialty & Generic Website

TCNNF has an Alpha Score of 41 out of 100 (weak), computed on Nov 4, 2026 from 2 of 4 sub-scores. 1 member of Congress disclosed 2 trades in TCNNF since 2026: 0 purchases and 2 sales, most recently Greg Stanton (partial sale, May 28, 2026).

$12.47
Last price on Sep 22, 2026
Source: Finnhub
Alpha Score
41
Weak

What is TCNNF's Alpha Score?

How it works →

Alpha Score of 41 reflects weak overall profile with strong momentum, poor quality. Based on 2 of 4 signals – score is capped at 75 until remaining data ingests.

Momentum
81
Strong
Quality
24
Poor

Computed from 2 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 4, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded Trulieve Cannabis Corp. (TCNNF)?

Members
1
Disclosed trades
2
Purchases
0
Sales
2

Most recent: Greg Stanton (partial sale, May 28, 2026); records start May 6, 2026.

PoliticianTrade dateTypeAmount
Greg Stanton
D-AZ · House
2026-05-28partial sale$100k – $250k
Greg Stanton
D-AZ · House
2026-05-06partial sale$15k – $50k

From STOCK Act periodic transaction reports. House filings as of Nov 9, 2026.

See all TCNNF political trades →

What are TCNNF's key statistics?

EPS (TTM)
-2.46
Beta
0.43
Net Margin
-41.55%
ROE
-44.03%
Debt / Equity
0.45
52W High
$12.93
52W Low
$7.82

Key statistics as of Nov 4, 2026

How does TCNNF's valuation compare with the Healthcare sector?

MetricTCNNFHealthcare medianCompanies in median
Net margin-41.55%3.60%175
Return on equity-44.03%2.93%201

Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 11, 2026). P/E excludes loss-making companies.

TCNNF price chart

Powered by TradingView

What does Trulieve Cannabis Corp. do?

Trulieve Cannabis Corp. is a vertically integrated cannabis company that focuses on the cultivation, production, and distribution of cannabis products for both medical and recreational use. As a leading player in the cannabis industry, Trulieve operates primarily in the United States, with a significant market presence in Florida where it was originally founded. The company is known for its wide array of products including smokable flower, tinctures, capsules, concentrates, and edibles, which are distributed through their expansive network of dispensaries. Trulieve’s commitment to quality and customer satisfaction is evident in its comprehensive supply chain management, from seed to sale, ensuring consistency and safety in its product offerings. Beyond its role as a market leader in Florida, Trulieve is expanding its footprint through strategic acquisitions and dispensary openings in other states, contributing to its influence and growth within the competitive cannabis market.

CEO
Ms. Kimberly Rivers J.D.
Employees
6,000
Market Cap
$2.20B
Ask about TCNNFAI research agent